Next Century Growth Investors LLC trimmed its stake in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW – Free Report) by 30.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 157,977 shares of the company’s stock after selling 70,568 shares during the quarter. Next Century Growth Investors LLC owned about 0.48% of Bowhead Specialty worth $5,611,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Charles Schwab Investment Management Inc. purchased a new position in Bowhead Specialty during the third quarter worth about $1,829,000. Geode Capital Management LLC purchased a new position in shares of Bowhead Specialty during the 3rd quarter worth approximately $4,691,000. Barclays PLC acquired a new stake in shares of Bowhead Specialty in the 3rd quarter valued at approximately $479,000. Bank of New York Mellon Corp lifted its holdings in shares of Bowhead Specialty by 180.6% in the 4th quarter. Bank of New York Mellon Corp now owns 29,550 shares of the company’s stock valued at $1,050,000 after buying an additional 19,018 shares during the period. Finally, Rhumbline Advisers boosted its stake in shares of Bowhead Specialty by 89.5% in the fourth quarter. Rhumbline Advisers now owns 12,601 shares of the company’s stock valued at $448,000 after buying an additional 5,953 shares in the last quarter.
Analyst Upgrades and Downgrades
A number of equities research analysts have commented on the company. JPMorgan Chase & Co. raised their target price on Bowhead Specialty from $30.00 to $35.00 and gave the company a “neutral” rating in a report on Tuesday. Keefe, Bruyette & Woods reduced their price objective on shares of Bowhead Specialty from $44.00 to $43.00 and set an “outperform” rating for the company in a research note on Wednesday. Finally, JMP Securities upped their target price on shares of Bowhead Specialty from $38.00 to $40.00 and gave the stock a “market outperform” rating in a research report on Friday. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $35.80.
Insider Activity at Bowhead Specialty
In other news, Director Ava Schnidman bought 1,493 shares of the business’s stock in a transaction that occurred on Friday, February 28th. The stock was purchased at an average price of $33.41 per share, with a total value of $49,881.13. Following the purchase, the director now owns 1,893 shares of the company’s stock, valued at $63,245.13. This trade represents a 373.25 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.
Bowhead Specialty Stock Down 0.1 %
NYSE:BOW opened at $37.91 on Friday. Bowhead Specialty Holdings Inc. has a 52-week low of $22.14 and a 52-week high of $42.29. The stock has a fifty day simple moving average of $35.76 and a 200-day simple moving average of $33.73.
Bowhead Specialty (NYSE:BOW – Get Free Report) last announced its earnings results on Tuesday, February 25th. The company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.07. The business had revenue of $184.77 million for the quarter, compared to analyst estimates of $102.12 million. As a group, research analysts predict that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current year.
Bowhead Specialty Company Profile
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Further Reading
- Five stocks we like better than Bowhead Specialty
- Financial Services Stocks Investing
- Delta Air Lines: This Phoenix Can Rise From the Ashes
- What is a penny stock? A comprehensive guide
- MarketBeat Week in Review — 04/07 – 04/11
- What to Know About Investing in Penny Stocks
- JPMorgan is a Buy, if You Can Handle The Volatility
Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.